Caffeine: Cognitive and physical performance enhancer or psychoactive drug?

Current Neuropharmacology

Volumn 13, Issue 1, 2015, Pages 71-88

  Cappelletti, Simone ^a   Piacentino, Daria ^b   Sani, Gabriele ^b   Aromatario, Mariarosaria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Abuse; Caffeine; Coffee; Dependence; Energy drinks; Safety doses; Toxicity

Indexed keywords

5 ACETAMIDO 6 FORMYLAMINO 3 METHYLURACIL; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM; CYCLIC GMP; CYCLOOXYGENASE 2; CYTOCHROME P450 1A2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HORMONE SENSITIVE LIPASE; PARAXANTHINE; PHOSPHODIESTERASE; PSYCHOTROPIC AGENT; CENTRAL STIMULANT AGENT; NOOTROPIC AGENT;

ALZHEIMER DISEASE; ANXIETY; ARTICLE; CACAO; CALCIUM MOBILIZATION; COFFEE; COGNITION; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG HALF LIFE; DRUG INTOXICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERANCE; DSM-5; DSM-IV-TR; ENERGY DRINK; ENZYME INHIBITION; FATTY ACID OXIDATION; GLYCOGEN MUSCLE LEVEL; HEART VENTRICLE EXTRASYSTOLE; HUMAN; META ANALYSIS (TOPIC); PARKINSON DISEASE; PHARMACODYNAMICS; PHYSICAL PERFORMANCE; QRS COMPLEX; QT PROLONGATION; SOFT DRINK; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW (TOPIC); TEA; ATHLETIC PERFORMANCE; DRUG UTILIZATION; META ANALYSIS; MORTALITY; SUBSTANCE-RELATED DISORDERS;

ATHLETIC PERFORMANCE; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG UTILIZATION; HUMANS; NOOTROPIC AGENTS; SUBSTANCE-RELATED DISORDERS;

EID: 84929320352     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X13666141210215655     Document Type: Article

References (190)

1. Lee, R.A.; Balick, M.J. Rx: Caffeine. Explore (NY), 2006, 2(1), 55- 59. http://dx.doi.org/10.1016/j.explore.2005.10.012
2. Weinberg, B.A.; Bealer, B. The World of Caffeine: The Science and Culture of the World's Most Popular Drug; Routledge: New York, 2001, pp. 1-41.
3. Porciúncula, L.O.; Sallaberry, C.; Mioranzza, S.; Botton, P.H.; Rosemberg. D.B. The Janus face of caffeine. Neurochem. Int., 2013, 63(6), 594-609. http://dx.doi.org/10.1016/j.neuint.2013.09. 009
4. Eskelinen, M.H.; Ngandu, T.; Tuomilehto, J.; Soininen, H.; Kivipelto, M. Midlife coffee and tea drinking and the risk of latelife dementia: a population-based CAIDE study. J. Alzheimers Dis., 2009, 16, 85-91. DOI: 10.3233/JAD-2009-0920
5. Espinosa, J.; Rocha, A.; Nunes, F.; Costa, M.S.; Schein, V.; Kazlauckas, V.; Kalinine, E.; Souza, D.O.; Cunha, R.A.; Porciúncula, L.O. Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia. J. Alzheimers Dis., 2013, 34, 509-518. DOI: 10.3233/JAD-111982
6. Dall'Igna, O.P.; Fett, P.; Gomes, M.W.; Souza, D.O.; Cunha, R.A.; Lara, D.R. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice. Exp. Neurol., 2007, 203, 241-245. http://dx.doi.org/10.1016/j. expneurol.2006.08.008
7. Cunha, R.A.; Agostinho, P.M. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J. Alzheimers Dis., 2010, 20 (Suppl 1), 95-116. 10.3233/JAD-2010-1408
8. Einöther, S.J.; Giesbrecht, T. Caffeine as an attention enhancer: reviewing existing assumptions. Psychopharmacology (Berl), 2013, 225(2), 251-274. http://dx.doi.org/10.1007/s00213-012-2917-4
9. Rogers, P.J.; Heatherley, S.V.; Mullings, E.L.; Smith, J.E. Faster but not smarter: effects of caffeine and caffeine withdrawal on alertness and performance. Psychopharmacology (Berl), 2013, 226(2), 229-240. http://dx.doi.org/10.1007/s00213-012-2889-4
10. Griffiths, R.R.; Mumford, G.K. Caffeine reinforcement, discrimination, tolerance, and physical dependence in laboratory animals and humans. In: Handbook of Experimental Pharmacology; Schuster, C.R., Kuhar, M.J., Eds.; Springer-Verlag: Heidelberg, 1996, pp. 315-341. http://dx.doi.org/10.1007/978-3-642-60963-3_9
11. Postuma, R.B.; Lang, A.E.; Munhoz, R.P.; Charland, K.; Pelletier, A.; Moscovich, M.; Filla, L.; Zanatta, D.; Rios Romenets, S.; Altman, R.; Chuang, R.; Shah, B. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology, 2012, 79(7), 651-658.
12. Chen, X.; Lan, X.; Roche, I.; Liu, R.; Geiger, J.D. Caffeine protects against MPTP induced blood-brain barrier dysfunction in mouse striatum. J. Neurochem., 2008, 107(4), 1147-1157.
13. Chen, J.F.; Xu, K.; Petzer, J.P.; Staal, R.; Xu, Y.H.; Beilstein, M.; Sonsalla, P.K.; Castagnoli, K.; Castagnoli, N. Jr.; Schwarzschild, M.A. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J. Neurosci., 2001, 21(10), 143. PubMed ID: 11319241
14. Another Reason to Have a Second Cup of Coffee?. Available at: http://www.cancer.org/cancer/news/expertvoices/post/2011/05/25/a nother-reason-to-have-a-second-cup-of-coffee.aspx. Accessed July 20, 2014.
15. Tavani, A.; LaVecchia, C. Coffee, decaffeinated coffee, tea and cancer of the colon and rectum: a review of epidemiological studies, 1990-2003. Cancer Causes Control., 2004, 15(8), 743-757. http://dx.doi.org/10.1023/b:caco.0000043415.28319.c1
16. Green Tea. Available at: http://www.cancer.org/treatment/ treatmentsandsideeffects/complementaryandalternativemedicine/he rbsvitaminsandminerals/green-tea. Accessed July 20, 2014.
17. Arnaud, M.J. Metabolism of caffeine and other components of coffee. In: Caffeine, coffee and health; Garattini, S., Ed.; Raven Press: New York, 1993, pp. 43-95.
18. Fredholm, B.B.; Bättig, K.; Holmén, J.; Nehlig, A.; Zvartau, E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev., 1999, 51(1), 83-133. PubMed ID: 10049999
19. Weathersbee, P.S.; Lodge, J.R. Caffeine: Its direct and indirect influence on reproduction. J. Reprod. Med., 1977, 19(2), 55-63. PubMed ID: 197235
20. Fenster, L.; Quale, C.; Hiatt, R.A.; Wilson, M.; Windham, G.C.; Benowitz, N.L. Rate of caffeine metabolism and risk of spontaneous abortion. Am. J. Epidemiol., 1998, 147(5), 503-510. http://dx.doi. org/10.1093/oxfordjournals.aje.a009477
21. Daly, J. Mechanism of action of caffeine. In: Caffeine, Coffee, and Health; Garattini, S., Ed.; Raven Press: New York, 1993, pp. 97- 149.
22. Benowitz, N.L. Clinical pharmacology of caffeine. Annu. Rev. Med., 1990, 41, 277-278. http://dx.doi.org/10.1146/annurev.me.41. 020190.001425
23. Safranow, K.; Machoy, Z. Methylated purines in urinary stones. Clinical Chem., 2005, 51(8), 1493-1498. http://dx.doi.org/10.1373/ clinchem.2005.048033
24. Mandel, H.G. Update on Caffeine consumption, disposition and action. Food Chem. Toxicol., 2002, 40(9), 1231-1234. http://dx.doi. org/10.1016/s0278-6915(02)00093-5
25. Klebanoff, M.A.; Levine, R.J.; Dersimonian, R.; Clemens, J.D.; Wilkins, D.G. Maternal serum paraxanthine, a caffeine metabolite, and the risk of spontaneous abortion. New Engl. J. Med., 1999, 341 (22), 1639-1644. http://dx.doi.org/10.1056/nejm199911253412202
26. Kalow, W.; Tang, B.K. Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking. Clin. Pharmacol. Ther., 1991, 49(1), 44-48. http://dx.doi.org/10.1038/ clpt.1991.8
27. Eteng, M.U.; Eyong, E.U.; Akpanyung, E.O.; Agiang, M.A.; Aremu, C.Y. Recent advances in caffeine and theobromine toxicities: a review. Plant Foods Hum. Nutr., 1997, 51(3), 231-243. http://dx. doi.org/10.1023/a:1007976831684
28. Tarka, S.M. Jr.; Arnaud, M.J.; Dvorchik, B.H.; Vesell, E.S. Theobromine kinetics and metabolic disposition. Clin. Pharmacol. Ther., 1983, 34(4), 546-555. http://dx.doi.org/10.1038/clpt.1983.212
29. Shively, C.A.; Tarka, S.M. Jr.; Arnaud, M.J.; Dvorchik, B.H.; Passananti, G.T.; Vesell, E.S. High levels of methylxanthines in chocolate do not alter theobromine disposition. Clin. Pharmacol. Ther., 1985, 37(4), 415-424. http://dx.doi.org/10.1038/clpt.1985. 65
30. Rostami-Hodjegan, A.; Nurminen, S.; Jackson, P.R.; Tucker, G.T. Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment. Pharmacogenetics, 1996, 6(2), 121-149. http://dx.doi.org/10.1097/00008571-199604000-00001
31. Lelo, A.; Birkett, D.J.; Robson, R.A.; Miners, J.O. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br. J. Clin. Pharmacol., 1986, 22(2), 177-182. http://dx.doi.org/10. 1111/j.1365-2125.1986.tb05246.x
32. Birkett, D.J.; Dahlquist, R.; Miners, J.O.; Lelo, A.; Billing, B. Comparison of theophylline and theobromine metabolism in man. Drug. Metab. Dispos., 1985, 13(6), 725-728. PubMed ID: 2867879
33. Gates, S.; Miners, J.O. Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism. Br. J. Clin. Pharmacol., 1999, 47(3), 299-305. http://dx.doi.org/10.1046/j.1365-2125.1999. 00890.x
34. Stavric, B. Methylxanthines: toxicity to humans. 1. Theophylline. Food Chem. Toxic., 1988, 26(6), 541-565. http://dx.doi.org/ 10.1016/0278-6915(88)90007-5
35. Aldridge, A.; Bailey, J.; Neims, A.H. The disposition of caffeine during and after pregnancy. Semin. Perinatol., 1981, 5(4), 31-34. PubMed ID: 7302604
36. Parsons, W.D.; Neims, A.H. Effect of smoking on caffeine clearance. Clin. Pharmacol. Ther., 1978, 24(1), 40-45. PubMed ID: 657717
37. Brown, C.R.; Jacob, P. 3rd.; Wilson, M.; Benowitz, N.L. Changes in rate and pattern of caffeine metabolism after cigarette abstinence. Clin. Pharmacol. Ther., 1988, 43(5), 488-491. . http://dx.doi.org/ 10.1038/clpt.1988.63
38. Cook, D.G.; Peacock, J.L.; Feyerabend, C.; Carey, I.M.; Jarvis, M.J.; Anderson, H.R.; Bland, J.M. Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: prospective population based study. BMJ., 1996, 313(7069), 1358- 1362. http://dx.doi.org/10.1136/bmj.313.7069.1358
39. Nakajima, M.; Yokoi, T.; Mizutani, M.; Kinoshita, M.; Funayama, M.; Kamataki, T. Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J. Biochem., 1999, 125(4), 803-808. http://dx.doi.org/ 10.1093/oxfordjournals.jbchem.a022352
40. Holtzman, S.G.; Mante, S.; Minneman, K.P. Role of adenosine receptors in caffeine tolerance. J. Pharmacol. Exp. Ther. 1991, 256(1), 62-68. PubMed ID: 1846425
41. Ribeiro, J.A.; Sebastião, A.M. Caffeine and adenosine. J. Alzheimers Dis., 2010, 20 (Suppl 1), 3-15.
42. Ferré, S.; Fredholm, B.B.; Morelli, M.; Popoli, P.; Fuxe, K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci., 1997, 20(10), 482-487. http://dx.doi.org/10.1016/s0166-2236(97)01096-5
43. Smits, P.; Boekema, P.; De Abreu, R.; Thien, T.; van 't Laar, A. Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J. Cardiovasc. Pharmacol., 1987, 10(2), 136-143. http://dx.doi.org/10.1097/00005344-198708000- 00002
44. Cameron, O.G.; Modell, J.G.; Hariharan, M. Caffeine and human cerebral blood flow: a positron emission tomography study. Life Sci., 1990, 47(13), 1141-1146.
45. Namdar, M.; Schepis, T.; Koepfli, P.; Gaemperli, O.; Siegrist, P.T.; Grathwohl, R.; Valenta, I.; Delaloye, R.; Klainguti, M.; Wyss, C.A.; Lüscher, T.F.; Kaufmann, P.A. Caffeine impairs myocardial blood flow response to physical exercise in patients with coronary artery disease as well as in age-matched controls. PLoS One, 2009, 4(5), 5665. http://dx.doi.org/10.1016/0024-3205(90)90174-p
46. Fastbom, J.; Pazos, A.; Palacios, J. M. The distribution of adenosine A1 receptors and 5'-nucleotidase in the brain of some commonly used experimental animals. Neuroscience, 1987, 22(3), 813-826. http://dx.doi.org/10.1016/0306-4522(87)92961-7
47. Goodman, R.R.; Synder, S.H. Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine. J. Neurosci., 1982, 2(9), 1230-1241.
48. Svenningsson, P.; Nomikos, G.G.; Fredholm, B.B. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J. Neurosci., 1999, 19(10), 4011-4022. PubMed ID: 10234030
49. Svenningsson, P.; Nomikos, G.G.; Ongini, E.; Fredholm, B.B. Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience, 1997, 79(3), 753-764. http://dx.doi.org/10.1016/s0306-4522(97)00046-8
50. Supinski, G.S.; Deal, E.C. Jr.; Kelsen, S.G. The effects of caffeine and theophylline on diaphragm contractility. Am. Rev. Respir. Dis, 1984, 130(3), 429-433. PubMed ID: 6476593
51. Endo, M. Calcium release from the sarcoplasmic reticulum. Physiol. Rev., 1977, 57(1), 71-108.
52. Tarnopolsky, M.A. Effect of caffeine on the neuromuscular system-potential as an ergogenic aid. Appl. Physiol. Nutr. Metab., 2008, 33(6), 1284-1289. http://dx.doi.org/10.1139/h08-121
53. Goldstein, E.R.; Ziegenfuss, T.; Kalman, D.; Kreider, R.; Campbell, B.; Wilborn, C.; Taylor, L.; Willoughby, D.; Stout, J.; Graves, B.S.; Wildman, R.; Ivy, J.L.; Spano, M.; Smith, A.E.; Antonio, J. International society of sports nutrition position stand: caffeine and performance. J. Int. Soc. Sports Nutr., 2010, 7(1), 5. http://dx.doi.org/10.1186/1550-2783-7-5
54. Osswald, H.; Schnermann, J. Methylxanthines and the kidney. Handb. Exp. Pharmacol., 2011, 200, 391-412. http://dx.doi.org/10. 1007/978-3-642-13443-2_15
55. Umemura, T.; Ueda, K.; Nishioka, K.; Hidaka, T.; Takemoto, H.; Nakamura, S.; Jitsuiki, D.; Soga, J.; Goto, C.; Chayama, K.; Yoshizumi, M.; Higashi, Y. Effects of acute administration of caffeine on vascular function. Am. J. Cardiol., 2006, 98(11), 1538- 1541. http://dx.doi.org/10.1016/j.amjcard.2006.06.058
56. Chesley, A.; Hultman, E.; Spriet, L.L. Effects of epinephrine infusion on muscle glycogenolysis during intense aerobic exercise. Am. J. Physiol. 1995, 268 (1 Pt 1), 127-134. PubMed ID: 7840170
57. Graham, T.E. Caffeine and exercise: metabolism, endurance and performance. Sports Med., 2001, 31(11), 785-807. http://dx.doi. org/10.2165/00007256-200131110-00002
58. Taylor, C.; Higham, D.; Close, G.L; Morton, J.P. The effect of adding caffeine to postexercise carbohydrate feeding on subsequent high-intensity interval-running capacity compared with carbohydrate alone. Int. J. Sport. Nutr. Exerc. Metab., 2011, 21(5), 410-416. PubMed ID: 21832305
59. Battram, D.S.; Shearer, J.; Robinson, D.; Graham, T.E. Caffeine ingestion does not impede the resynthesis of proglycogen and macroglycogen after prolonged exercise and carbohydrate supplementation in humans. J. Appl. Physiol. (1985), 2004, 96(3), 943-950. http://dx.doi.org/10.1152/japplphysiol.00745.2003
60. Pedersen, D.J.; Lessard S.J.; Coffey, V.G.; Churchley, E.G.; Wootton, A,M.; Ng, T.; Watt, M.J.; Hawley, J.A. High rates of muscle glycogen resynthesis after exhaustive exercise when carbohydrate is coingested with caffeine. J. Appl. Physiol. (1985), 2008, 105(1), 7-13. http://dx.doi.org/10.1152/japplphysiol.01121.2007
61. Spriet, L.L.; MacLean, D.A.; Dyck, D.J.; Hultman, E.; Cederblad, G.; Graham, T.E. Caffeine ingestion and muscle metabolism during prolonged exercise in humans. Am. J. Physiol., 1992, 262 (6 Pt 1), 891-898. PubMed ID: 1616022
62. Rush, J.W.; Spriet, L.L. Skeletal muscle glycogen phosphorylase a kinetics: effects of adenine nucleotides and caffeine. J. Appl. Physiol. (1985), 2001, 91(5), 2071-2078. PubMed ID: 11641346
63. Rudolph, T.; Knudsen, K. A case of fatal caffeine poisoning. Acta Anaesthesiol. Scand., 2010, 54(4), 521-523. http://dx.doi.org/10. 1111/j.1399-6576.2009.02201.x
64. Klatsky, A.L.; Hasan, A.S.; Armstrong, M.A.; Udaltsova, N.; Morton, C. Coffee, caffeine, and risk of hospitalization for arrhythmias. Perm. J., 2011, 15(3), 19-25.
65. Mehta, A.; Jain, A.C.; Mehta, M.C.; Billie, M. Caffeine and cardiac arrhythmias. An experimental study in dogs with review of literature. Acta Cardiol., 1997, 52(3), 273-283. PubMed ID: 9217918
66. Usman, A.; Jawaid, A. Hypertension in a young boy: an energy drink effect. BMC Res. Notes, 2012, 5, 591.
67. Berger, A.J.; Alford, K. Cardiac arrest in a young man following excess consumption of caffeinated "energy drinks". Med. J. Aust., 2009, 190(1), 41-43.
68. Balasubramaniam, R; Chawla, S.; Grace, A.A.; Huang, C.L. Caffeine-induced arrhythmias in murine hearts parallel changes in cellular Ca(2+) homeostasis. Am. J. Physiol. Heart Circ. Physiol., 2005, 289(4), H1584-1593. http://dx.doi.org/10.1152/ajpheart. 01250.2004
69. Daniel, J.; Pelchovitz, M.D.; Jeffrey, J.; Goldberger, M.D. Caffeine and Cardiac Arrhythmias: A Review of the Evidence. Am. J. Med., 2011, 124, 284-289. http://dx.doi.org/10.1016/j.amjmed.2010.10.017
70. Prineas, R.J.; Jacobs, D.R. Jr; Crow, R.S.; Blackburn, H. Coffee, tea and VPB. J. Chronic Dis., 1980, 33(2), 67-72.
71. Gould, L.; Reddy, C.V.; Oh, K.C.; Kim, S.G.; Becker, W. Electrophysiologic properties of coffee in man. J. Clin. Pharmacol., 1979, 19(1), 46-55. http://dx.doi.org/10.1002/j.1552-4604.1979.tb01616.x
72. Dobmeyer, D.J.; Stine, R.A.; Leier, C.V.; Greenberg, R.; Schaal, S.F. The arrhythmogenic effects of caffeine in human beings. N. Engl. J. Med., 1983, 308(14), 814-816. http://dx.doi.org/10.1056/ nejm198304073081405
73. Caron, M.F.; Song, J.; Ammar, R.; Kluger, J.; White, C.M. An evaluation of the change in electrocardiographic P-wave variables after acute caffeine ingestion in normal volunteers. J. Clin. Pharm. Ther., 2001, 26(2), 145-148.
74. Steinke, L.; Lanfear, D.E.; Dhanapal, V.; Kalus, J.S. Effect of "energy drink" consumption on hemodynamic and electrocardio graphic parameters in healthy young adults. Ann. Pharmacother., 2009, 43(4), 596-602. http://dx.doi.org/10.1345/aph.1l614
75. Ammar, R.; Song, J.C.; Kluger, J.; White, C.M. Evaluation of electrocardiographic and hemodynamic effects of caffeine with acute dosing in healthy volunteers. Pharmacotherapy., 2001, 21(4), 437-442. http://dx.doi.org/10.1592/phco.21.5.437.34502
76. Donnerstein, R.L.; Zhu, D.; Samson, R.; Bender, A.M.; Goldberg, S.J. Acute effects of caffeine ingestion on signal-averaged electrocardiograms. Am. Heart J., 1998, 136(4 Pt 1), 643-646. http://dx.doi.org/10.1016/s0002-8703(98)70011-0
77. Sutherland, D.J.; McPherson, D.D.; Renton, K.W.; Spencer, C.A.; Montague, T.J. The effect of caffeine on cardiac rate, rhythm, and ventricular repolarization. Analysis of 18 normal subjects and 18 patients with primary ventricular dysrhythmia. Chest., 1985, 87(3), 319-324. PubMed ID: 3971755
78. Chelsky, L.B.; Cutler, J.E.; Griffith, K.; Kron, J.; McClelland, J.H.; McAnulty, J.H. Caffeine and ventricular arrhythmias. An electrophysiological approach. JAMA., 1990, 264(17), 2236-2240.
79. Jackman, M.; Wendling, P.; Friars, D.; Graham, T.E. Metabolic catecholamine, and endurance responses to caffeine during intense exercise. J. Appl. Physiol., 1996, 81(4), 1658-1663. PubMed ID: 8904583
80. Cheng, M.; Hu, Z.; Lu, X.; Huang, J.; Gu, D. Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies. Can. J. Cardiol., 2014, 30(4), 448-454. http://dx.doi.org/10.1016/j.cjca.2013.12.026
81. Corti, R.; Binggeli, C.; Sudano, I.; Spieker, L.; Hänseler, E.; Ruschitzka, F.; Chaplin, W.F.; Lüscher, T.F.; Noll, G. Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking. Circulation, 2002, 106(23), 2935-2940. http://dx.doi.org/10.1161/01.cir.0000046228.97025.3a
82. Swartz, M.F.; Fink, G.W.; Sarwar, M.F.; Hicks, G.L.; Yu, Y.; Hu, R.; Lutz, C.J.; Taffet, S.M.; Jalife, J. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. J. Am. Coll. Cardiol., 2012, 60(18), 1799-1806. http:// dx.doi.org/10.1016/j.jacc.2012.06.048
83. Anty, R.; Marjoux, S.; Iannelli, A.; Patouraux, S.; Schneck, A.S.; Bonnafous, S.; Gire, C.; Amzolini, A.; Ben-Amor, I.; Saint-Paul, M.C.; Mariné-Barjoan, E.; Pariente, A.; Gugenheim, J.; Gual, P.; Tran, A. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J. Hepatol., 2012, 57(5), 1090-1096. http://dx.doi.org/10.1016/j.jhep. 2012.07.014
84. Arauz, J.; Moreno, M.G.; Cortés-Reynosa, P.; Salazar, E.P.; Muriel, P. Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage. J. Appl. Toxicol., 2013, 33(9), 970-979. http://dx.doi.org/10.1002/jat.2788
85. Arauz, J.; Zarco, N.; Segovia, J.; Shibayama, M.; Tsutsumi, V.; Muriel, P. Caffeine prevents experimental liver fibrosis by blocking the expression of TGF-β. Eur. J. Gastroenterol. Hepatol., 2014, 26(2), 164-173.
86. Happonen, P.; Voutilainen, S.; Salonen, J.T. Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men. J. Nutr., 2004, 134(9), 2381-2386.
87. Hartley, T.R.; Lovallo, W.R.; Whitsett, T.L. Cardiovascular effects of caffeine in men and women. Am. J. Cardiol., 2004, 93(8), 1022- 1026. http://dx.doi.org/10.1016/j.amjcard.2003.12.057
88. Savoca, M.R.; MacKey, M.L.; Evans, C.D.; Wilson, M.; Ludwig, D.A.; Harshfield, G.A. Association of ambulatory blood pressure and dietary caffeine in adolescents. Am. J. Hypertens., 2005, 18(1), 116-120. http://dx.doi.org/10.1016/j.amjhyper.2004.08.011
89. Palatini, P.; Ceolotto, G.; Ragazzo, F; Dorigatti, F.; Saladini, F.; Papparella, I.; Mos, L.; Zanata, G.; Santonastaso, M. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J. Hypertens., 2009, 27(8), 1594-1601. http://dx.doi.org/10.1097/hjh.0b013e32832ba850
90. Whitsett, T.L.; Manion, C.V.; Christensen, H.D. Cardiovascular effects of coffee and caffeine. Am. J. Cardiol., 1984, 53(7), 918- 922. http://dx.doi.org/10.1016/0002-9149(84)90525-3
91. Böttcher, M.; Czernin, J.; Sun, K.T.; Phelps, M.E.; Schelbert, H.R. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J. Nucl. Med., 1995, 36(11), 2016- 2021. PubMed ID: 7472591
92. Mahmud, A.; Feely, J. Acute effect of caffeine on arterial stiffness and aortic pressure waveform. Hypertension, 2001, 38(2), 227-231. http://dx.doi.org/10.1161/01.hyp.38.2.227
93. Hatano, Y.; Mizumoto, K.; Yoshiyama, T.; Yamamoto, M.; Iranami, H. Endothelium-dependent and -independent vasodilation of isolated rat aorta induced by caffeine. Am. J. Physiol., 1995, 269(5 Pt 2), 1679-1684. PubMed ID: 7503265
94. Banerjee, P.; Ali, Z.; Levine, B.; Fowler, D.R. Fatal caffeine intoxication: a series of eight cases from 1999 to 2009. J. Forensic Sci., 2014, 59(3), 865-868. DOI: 10.1111/1556-4029.12387
95. Karatzis, E.; Papaioannou, T.G.; Aznaouridis, K.; Karatzi, K.; Stamatelopoulos, K.; Zampelas, A.; Papamichael, C.; Lekakis, J.; Mavrikakis, M. Acute effects of caffeine on blood pressure and wave reflections in healthy subjects: should we consider monitoring central blood pressure? Int. J. Cardiol., 2005, 98(3), 425-430. http://dx.doi.org/10.1016/j.ijcard.2003.11.013
96. Forman, J.; Aizer, A.; Young, C.R. Myocardial infarction resulting from caffeine overdose in an anorectic woman. Ann. Emerg. Med., 1997, 29(1), 178-180. http://dx.doi.org/10.1016/s0196-0644(97) 70326-3
97. Wilson, R.E.; Kado, H.S.; Samson, R.; Miller, A.B. A case of caffeine-induced coronary artery vasospasm of a 17-year-old male. Cardiovasc. Toxicol., 2012, 12(2), 175-179. http://dx.doi.org/10. 1007/s12012-011-9152-9
98. Baum, M.; Weiss, M. The influence of a taurine containing drink on cardiac parameters before and after exercise measured by echocardiography. Amino Acids, 2001, 20(1), 75-82. http://dx.doi. org/10.1007/s007260170067
99. Benjo, A.M.; Pineda, A.M.; Nascimento, F.O.; Zamora, C.; Lamas, G.A.; Escolar, E. Left main coronary artery acute thrombosis related to energy drink intake. Circulation, 2012, 125(11), 1447-1448. http://dx.doi.org/10.1161/circulationaha.111.086017
100. Worthley, M.I.; Prabhu, A.; De Sciscio, P.; Schultz, C.; Sanders, P.; Willoughby, S.R. Detrimental effects of energy drink consumption on platelet and endothelial function. Am. J. Med., 2010, 123(2), 184-187. http://dx.doi.org/10.1016/j.amjmed.2009.09.013
101. Grobbee, D.E.; Rimm, E.B.; Giovannucci, E.; Colditz, G.; Stampfer, M.; Willett, W. Coffee, caffeine, and cardiovascular disease in men. N. Engl. J. Med., 1990, 323(15), 1026-1032. http:// dx.doi.org/10.1056/nejm199010113231504
102. Zhang, W.; Lopez-Garcia, E.; Li, T.Y.; Hu, F.B.; van Dam, R.M. Coffee consumption and risk of cardiovascular diseases and allcause mortality among men with type 2 diabetes. Diabetes Care, 2009, 32(6), 1043-1045. http://dx.doi.org/10.2337/dc08-2251
103. Lopez-Garcia, E.; van Dam, R.M.; Willett, W.C.; Rimm, E.B.; Manson, J.E.; Stampfer, M.J.; Rexrode, K.M.; Hu, F.B. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation, 2006, 113(17), 2045-2053. http://dx.doi.org/10.1161/circulationaha.105.598664
104. Hirsch, A.T.; Gervino, E.V.; Nakao, S.; Come, P.C.; Silverman, K.J.; Grossman, W. The effect of caffeine on exercise tolerance and left ventricular function in patients with coronary artery disease. Ann. Intern. Med., 1989, 110(8), 593-598. PubMed ID: 2930092
105. Greenberg, J.A.; Dunbar, C.C.; Schnoll, R.; Kokolis, R.; Kokolis, S.; Kassotis, J. Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis. Am. J. Clin. Nutr., 2007, 85(2), 392-398. PubMed ID: 17284734
106. Leathwood, P.D.; Pollet, P. Diet-induced mood changes in normal populations. J. Psychiatr. Res., 1982, 17(2), 147-154.
107. Rusted, J. Caffeine and cognitive performance: Effects on mood or mental processing. In: Caffeine and behavior: Current views and research trends; Gupta, B.S., Gupta, U., Eds.; CRC Press: Washington, 1999; pp. 221-229.
108. Baldwin, H.A.; File, S.E. Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors. Pharmacol. Biochem. Behav., 1989, 32(1), 181-186. http://dx.doi. org/10.1016/0091-3057(89)90230-x
109. Loke, W.H.; Hinrichs, J.V.; Ghoneim, M.M. Caffeine and diazepam: separate and combined effects on mood, memory, and psychomotor performance. Psychopharmacology (Berl), 1985, 87(3), 344-350. http://dx.doi.org/10.1007/bf00432719
110. Sicard, B.A.; Perault, M.C.; Enslen, M.; Chauffard, F.; Vandel, B.; Tachon, P. The effects of 600 mg of slow release caffeine on mood and alertness. Aviat. Space Environ. Med., 1996, 67(9), 859-862. PubMed ID: 9025802
111. Nehlig, A. Is caffeine a cognitive enhancer? J. Alzheimers Dis., 2010, 20 (Suppl 1), 85-94. http://dx.doi.org/10.1007/s00213-005-0084-6
112. James, J.E.; Rogers, P.J. Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation. Psychopharmacology (Berl), 2005, 182(1), 1-8. http://dx.doi.org/ 10.1007/s00213-005-0084-6
113. Jarvis, M.J. Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology (Berl), 1993, 110(1-2), 45-52. http://dx.doi.org/10.1007/bf02246949
114. Committee on Military Nutrition Research. Caffeine for the sustainment of mental task performance. Formulations for military operations; National Academy Press: Washington, 2001, pp. 61-65.
115. Bhattacharya, S.K.; Satyan, K.S.; Chakrabarti, A. Anxiogenic action of caffeine: an experimental study in rats. J. Psychopharmacol., 1997, 11(3), 219-224. http://dx.doi.org/10.1177/026988119701100304
116. El Yacoubi, M.; Ledent, C.; Parmentier, M.; Costentin, J.; Vaugeois, J.M. The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists. Psychopharmacology (Berl), 2000, 148(2), 153-163. http://dx.doi.org/ 10.1007/s002130050037
117. Sawyer, D.A.; Julia, H.L.; Turin, A.C. Caffeine and human behavior: arousal, anxiety, and performance effects. J. Behav. Med., 1982, 5(4), 415-439. http://dx.doi.org/10.1007/bf00845371
118. Rogers, P.J.; Hohoff, C.; Heatherley, S.V.; Mullings, E.L.; Maxfield, P.J.; Evershed, R.P.; Deckert, J.; Nutt, D.J. Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology, 2010, 35(9), 1973-1983.
119. Rhoads, D.E.; Huggler, A.L.; Rhoads, L. Acute and adaptive motor responses to caffeine in adolescent and adult rats. J. Pharmacol. Biochem. Behav., 2011, 99(1), 81-86. http://dx.doi.org/10.1016/ j.pbb.2011.04.001
120. Kaplan, G.B.; Greenblatt, D.J.; Ehrenberg, B.L.; Goddard, J.E.; Cotreau, M.M.; Harmatz, J.S.; Shader R.I. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J. Clin. Pharmacol., 1997, 37(8), 693-703. http://dx.doi.org/10. 1002/j.1552-4604.1997.tb04356.x
121. Sudakov, S.K.; Medvedeva, O.F.; Rusakova, I.V.; Figurina, I.B. Effect of short-term and chronic caffeine intake on rats with various anxiety level. Bull. Exp. Biol. Med., 2001, 132(6), 1177- 1179. http://dx.doi.org/10.1023/a:1014511415473
122. Maia, L.; de Mendonça, A. Does caffeine intake protect from Alzheimer's disease? Eur. J. Neurol., 2002, 9(4), 377-382. http:// dx.doi.org/10.1046/j.1468-1331.2002.00421.x
123. Ritchie, K.; Carrière, I.; de Mendonca, A.; Portet, F.; Dartigues, J.F.; Rouaud, O.; Barberger-Gateau, P.; Ancelin, M.L. The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology, 2007, 69(6), 536-545. http://dx.doi. org/10.1212/01.wnl.0000266670.35219.0c
124. Joghataie, M.T.; Roghani, M.; Negahdar, F.; Hashemi, L. Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence. Parkinsonism Relat. Disord., 2004, 10(8), 465-468. http://dx.doi.org/10.1016/j.parkreldis.2004.06.004
125. Glade, M.J. Caffeine-Not just a stimulant. Nutrition, 2010, 26(10), 932-938. http://dx.doi.org/10.1016/j.nut.2010.08.004
126. Snel, J.; Lorist, M.M. Effects of caffeine on sleep and cognition. Prog. Brain Res., 2011, 190, 105-117.
127. Doré, A.S.; Robertson, N.; Errey, J.C.; Ng, I.; Hollenstein, K.; Tehan, B.; Hurrell, E.; Bennett, K.; Congreve, M.; Magnani, F.; Tate, C.G.; Weir, M.; Marshall, F.H. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure, 2011, 19(9), 1283-1293. DOI: 10. 1016/j.str.2011.06.014
128. Sebastião, A.M.; Ribeiro, J.A. Adenosine receptors and the central nervous system. Handb. Exp. Pharmacol., 2009, 193, 471-534. http://dx.doi.org/10.1007/978-3-540-89615-9_16
129. Federico, S.; Spalluto, G. Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligands. Expert Opin. Ther. Pat., 2012, 22(4), 369-390. http://dx.doi.org/10.1517/ 13543776.2012.669375
130. Eskelinen, M.H.; Kivipelto, M. Caffeine as a protective factor in dementia and Alzheimer's disease. J. Alzheimers Dis., 2010, 20, 167-174. DOI: 10.3233/JAD-2010-1404
131. Rosim, F.E.; Persike, D.S.; Nehlig, A.; Amorim, R.P.; de Oliveira, D.M.; Fernandes, M.J. Differential neuroprotection by A(1) receptor activation and A(2A) receptor inhibition following pilocarpine-induced status epilepticus. Epilepsy Behav., 2011, 22(2), 207-213. http://dx.doi.org/10.1016/j.yebeh.2011.07.004
132. Schenone, S.; Brullo, C.; Musumeci, F.; Bruno, O.; Botta, M. A1 receptors ligands: past, present,and future trends. Curr. Top. Med. Chem., 2010, 10(9), 878-901. http://dx.doi.org/10.2174/ 156802610791268729
133. Xiao, D.; Cassin, J.J.; Healy, B.; Burdett, T.C.; Chen, J.F.; Fredholm, B.B.; Schwarzschild, M.A. Deletion of adenosine A₁ or A(₂A) receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease. Brain Res., 2011, 1367, 310-318. http://dx.doi.org/10.1016/j.brainres.2010.08.099
134. Camilo, F.; Goldstein, L.B. Seizures and epilepsy after ischemic stroke. Stroke, 2004, 35(7), 1769-1775. http://dx.doi.org/10.1161/ 01.str.0000130989.17100.96
135. Chen, J.F.; Chern, Y. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies. Handb. Exp. Pharmacol., 2011, 200, 267-310. http://dx.doi.org/10. 1007/978-3-642-13443-2_10
136. Cupino, T.L.; Zabel, M.K. Alzheimer's silent partner: cerebral amyloid angiopathy. Transl. Stroke Res., 2014, 5(3), 330-337. http://dx.doi.org/10.1007/s12975-013-0309-7
137. Salvemini, D.; Kim, S.F.; Mollace, V. Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2013, 304(7), 473-487. http://dx.doi.org/10.1152/ ajpregu.00355.2012
138. Yadav, S.; Gupta, S.P.; Srivastava, G.; Srivastava, P.K.; Singh. M.P. Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse. Neurochem. Res., 2012, 37(4), 875-884. http://dx.doi. org/10.1007/s11064-011-0682-0
139. Chu, Y.F.; Chang, W.H.; Black, R.M.; Liu, J.R.; Sompol, P.; Chen, Y.; Wei, H.; Zhao, Q.; Cheng, I,H. Crude caffeine reduces memory impairment and amyloid β(1-42) levels in an Alzheimer's mouse model. Food Chem., 2012, 135(3), 2095-2102. http://dx.doi.org/10. 1016/j.foodchem.2012.04.148
140. Palacios, N.; Gao, X.; McCullough, M.L.; Caffeine and risk of Parkinson's disease in a large cohort of men and women. Mov. Disord., 2012, 27(10), 1276-1282. http://dx.doi.org/10.1002/mds.25076
141. Sonsalla, P.K.; Wong, L.Y.; Harris, S.L. Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease. Exp. Neurol., 2012, 234(2), 482-487. http://dx.doi.org/10.1016/j.expneurol.2012.01.022
142. Prasanthi, J.R.; Dasari, B.; Marwarha, G. Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic. Biol. Med., 2010, 49(7), 1212-1220. http://dx.doi.org/10.1016/ j.freeradbiomed.2010.07.007
143. Chen, X.; Ghribi, O.; Geiger, J.D. Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J. Alzheimers Dis., 2010, 20 (Suppl 1), 127-141. DOI: 10.3233/JAD-2010-1376
144. Dragicevic, N.; Delic, V.; Cao, C.; Copes, N.; Lin, X.; Mamcarz, M.; Wang, L.; Arendash, G.W.; Bradshaw, P.C. Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells. Neuropharmacology, 2012, 63(8), 1368-1379. http://dx.doi.org/10.1016/j.neuropharm.2012.08.018
145. Gao, Y.; Phillis, J.W. CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. Life Sci., 1994, 55(3), 61-65. http://dx.doi.org/10.1016/ 0024-3205(94)00889-2
146. Laska, E.M.; Sunshine, A.; Mueller, F.; Elvers, W.B.; Siegel, C.; Rubin, A. Caffeine as an analgesic adjuvant. JAMA, 1984, 251(13), 1711-1718. http://dx.doi.org/10.1001/jama.251.13.1711
147. Diamond, S.; Balm, T.K.; Freitag, F.G. Ibuprofen plus caffeine in the treatment of tension-type headache. Clin. Pharmacol. Ther., 2000, 68(3), 312-319. http://dx.doi.org/10.1067/mcp.2000.109353
148. Ward, N.; Whitney, C.; Avery, D.; Dunner, D. The analgesic effects of caffeine in headache. Pain, 1991, 44(2), 151-155. http:// dx.doi.org/10.1016/0304-3959(91)90129-l
149. Yücel, A.; Ozyalçin, S.; Talu, G.K.; Yücel, E.C.; Erdine, S. Intravenous administration of caffeine sodium benzoate for postdural puncture headache. Reg. Anesth. Pain Med., 1999, 24(1), 51-54. http://dx.doi.org/10.1097/00115550-199924010-00010
150. Esmaoglu, A.; Akpinar, H.; Uğur, F. Oral multidose caffeineparacetamol combination is not effective for the prophylaxis of postdural puncture headache. J. Clin. Anesth., 2005, 17(1), 58-61. http://dx.doi.org/10.1016/j.jclinane.2004.04.003
151. Shapiro, R.E. Caffeine and headaches. Curr. Pain Headache Rep., 2008, 12(4), 311-315. http://dx.doi.org/10.1007/s11916-008-0052-z
152. Griffiths, R.R.; Woodson, P.P. Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology (Berl), 1988, 94(4), 437-451. http://dx.doi.org/10.1007/bf00212836
153. Griffiths, R.R.; Evans, S.M.; Heishman, S.J.; Preston, K.L.; Sannerud, C.A; Wolf, B.; Woodson, P.P. Low-dose caffeine physical dependence in humans. J. Pharmacol. Exp. Ther., 1990, 255(3), 1123-1132. PubMed ID: 2262896
154. Lovallo, W.R.; Whitsett, T.L.; al'Absi, M.; Sung, B.H.; Vincent, A.S.; Wilson, M.F. Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels. Psychosom. Med., 2005, 67(5), 734-739. DOI: 10.1097/01.psy.0000181270. 20036.06
155. Dager, S.R.; Layton, M.E.; Strauss, W.; Richards, T.L.; Heide, A.; Friedman, S.D.; Artru, AA, Hayes CE, Posse S. Human brain metabolic response to caffeine and the effects of tolerance. Am. J. Psychiat., 1999, 156(2), 229-237.
156. James, J.E. Critical review of dietary caffeine and blood pressure: a relationship that should be taken more seriously. Psychosom. Med., 2004, 66(1), 63-71. http://dx.doi.org/10.1097/10.psy.0000107884. 78247.f9
157. Lovallo, W.R.; Wilson, M.F.; Vincent, A.S.; Sung, B.H.; McKey, B.S.; Whitsett, T.L. Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption. Hypertension, 2004, 43(4), 760-765. http://dx.doi.org/10.1161/ 01.hyp.0000120965.63962.93
158. Eisenberg, S. Looking for the Perfect Brew. Sci. News, 1988, 133, 252-253.
159. Cherniske, S. Caffeine Blues: Wake Up to the Hidden Dangers of America's #1 Drug, First ed.; Warner Books Inc: New York, 1998, pp. 35.
160. Reissig, C.J.; Strain, E.C.; Griffiths, R.R. Caffeinated energy drinks- a growing problem. Drug Alcohol Dependence, 2009, 99(1-3), 1-10.
161. Kashkin, K.B.; Kleber, H.D. Hooked on hormones? An anabolic steroid addiction hypothesis. JAMA, 1989, 262(22), 3166-3170.
162. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revision (DSMIV- TR); APA: Washington, 2000.
163. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); APA: Arlington, 2013.
164. WHO. Lexicon of alcohol and drug terms. World Health Organization: Geneva, 1995.
165. Verheul, R.; van den Brink, W.; Geerlings, P. A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol., 1999, 34(2), 197-222.
166. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines; World Health Organization: Geneva, 1992.
167. Greden, J.F. Anxiety or caffeinism: a diagnostic dilemma. Am. J. Psychiatry, 1974, 131(10), 1089-1092.
168. Nawrot, P.; Jordan, S.; Eastwood, J.; Rotstein, J.; Hugenholtz, A.; Feeley, M. Effects of caffeine on human health. Food Addit. Contam., 2003, 20(1), 1-30. http://dx.doi.org/10.1080/ 0265203021000007840
169. Higdon, J.V.; Frei, B. Coffee and health: a review of recent human research. Crit. Rev. Food Sci. Nutr., 2006, 46(2), 101-123. http://dx.doi.org/10.1080/10408390500400009
170. Moffatt, A.C.; Osselton, M.D.; Widdop, B.; Galichet, L.Y. Clarke's Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids and Postmortem Material, Fourth ed.; Pharmaceutical Press: London, 2011, p. 36.
171. Dimaio, V.J.; Garriott, J.C. Lethal caffeine poisoning in a child. Forensic Sci., 1974, 3(3), 275-278. http://dx.doi.org/10.1016/0300- 9432(74)90056-9
172. Turner, J.E.; Cravey, R.H. A fatal ingestion of caffeine. Clin. Toxicol., 1977, 10(3), 341-344. http://dx.doi.org/10.3109/ 15563657708992428
173. McGee, M.B. Caffeine poisoning in a 19-year-old female. J. Forensic Sci., 1980, 25(1), 29-32. PubMed ID: 7391779
174. Bryant, J. Suicide by ingestion of caffeine. Arch. Pathol. Lab. Med., 1981, 105(12), 685-686. PubMed ID: 6895464
175. Chaturvedi, A.K.; Rao, N.G.; McCoy, F.E. A multi-chemical death involving caffeine, nicotine and malathion. Forensic Sci. Int., 1983, 23(2-3), 265-275. http://dx.doi.org/10.1016/0379-0738(83)90155-x
176. Garriott, J.C.; Simmons, L.M.; Poklis, A.; Mackell, M.A. Five cases of fatal overdose from caffeine-containing "look-alike" drugs. J. Anal. Toxicol., 1985, 9(3), 141-143. http://dx.doi.org/10. 1093/jat/9.3.141
177. Winek, C.L.; Wahba, W.; Williams, K.; Blenko, J.; Janssen, J. Caffeine fatality: a case report. Forensic Sci. Int., 1985, 29(3-4), 207-211. PubMed ID: 4076952
178. Morrow, P.L. Caffeine toxicity: a case of child abuse by drug ingestion. J. Forensic Sci., 1987, 32(6), 1801-1805. PubMed ID: 3323412
179. Mrvos, R.M.; Reilly, P.E.; Dean, B.S.; Krenzelok, E.P. Massive caffeine ingestion resulting in death. Vet. Hum. Toxicol., 1989, 31(6), 571-572. PubMed ID: 2617841
180. Riesselmann, B.; Rosenbaum, F.; Roscher, S.; Schneider, V. Fatal caffeine intoxication. Forensic Sci. Int., 1999, 103, 49-52. http://dx.doi.org/10.1016/s0379-0738(99)00073-0
181. Holmgren, P.; Nordén-Pettersson, L.; Ahlner, J. Caffeine fatalities-four case reports. Forensic Sci. In., 2004, 139(1), 71-73. http://dx. doi.org/10.1016/j.forsciint.2003.09.019
182. Kerrigan, S.; Lindsey, T. Fatal caffeine overdose: two case reports. Forensic Sci. Int., 2005, 153(1), 67-69. http://dx.doi.org/10.1016/ j.forsciint.2005.04.016
183. Thelander, G.; Jönsson, A.K.; Personne, M.; Forsberg, G.S.; Lundqvist, K.M.; Ahlner, J. Caffeine fatalities-do sales restrictions prevent intentional intoxications? Clin. Toxicol. (Phila)., 2010, 48(4), 354-358. http://dx.doi.org/10.3109/15563650903586752
184. Jabbar, S.B.; Hanly, M.G. Fatal Ceffeine overdose: a case report and review of literature. Am. J. Forensic Med. Pathol., 2013, 34(4), 321-324. http://dx.doi.org/10.1097/paf.0000000000000058
185. Jantos, R.; Stein, K.M.; Flechtenmacher, C.; Skopp, G. A fatal case involving a caffeine-containing fat burner. Drug Test. Anal., 2013, 5(9-10), 773-776. http://dx.doi.org/10.1002/dta.1485
186. Bonsignore, A.; Sblano, S.; Pozzi, F.; Ventura, F.; Dell'erba, A.; Palmiere, C. A case of suicide by ingestion of caffeine. Forensic Sci. Med. Pathol., 2014, 10 (3), 448-451. http://dx.doi.org/ 10.1007/s12024-014-9571-6
187. Bernstein, G.A.; Carroll, M.E.; Thuras, P.D.; Cosgrove, K.P.; Roth, M.E. Caffeine dependence in teenagers. Drug Alcohol Depend., 2002, 66(1), 1-6. http://dx.doi.org/10.1016/s0376-8716(01)00181-8
188. Oberstar, J.V.; Bernstein, G.A.; Thuras, P.D. Caffeine use and dependence in adolescents: one-year follow-up. J. Child Adolesc. Psychopharmacol., 2002, 12(2), 127-135. http://dx.doi.org/10.1089/ 104454602760219162
189. Strain, E.C.; Mumford, G.K.; Silverman, K.; Griffiths, R.R. Caffeine dependence syndrome. Evidence from case histories and experimental evaluations. JAMA, 1994, 272(13), 1043-1048. http://dx.doi.org/10.1001/jama.272.13.1043
190. Svikis, D.S.; Berger, N.; Haug, N.A.; Griffiths, R.R. Caffeine dependence in combination with a family history of alcoholism as a predictor of continued use of caffeine during pregnancy. Am. J. Psychiatry, 2005, 162(12), 2344-2351. http://dx.doi.org/10.1176/ appi.ajp.162.12.2344